Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Development of a new reproductive tissue cryopreservation clinical service for children: the Oxford programme.

Lakhoo K, Davies J, Chakraborty S, Berg S, Tennyson R, Fowler D, Manek S, Verrill C, Lane S.

Pediatr Surg Int. 2019 Jul 2. doi: 10.1007/s00383-019-04503-3. [Epub ahead of print]

PMID:
31267143
2.

Reply to Milan Hora's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.

Macklin PS, Sullivan ME, Tapping CR, Webster GM, Roberts ISD, Verrill CL, Browning L.

Eur Urol. 2019 Jun 26. pii: S0302-2838(19)30505-6. doi: 10.1016/j.eururo.2019.06.020. [Epub ahead of print] No abstract available.

PMID:
31255422
3.

Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses.

Abd Hamid M, Wang RZ, Yao X, Fan P, Li X, Chang XM, Feng Y, Jones S, Maldonado-Perez D, Waugh C, Verrill C, Simmons A, Cerundolo V, McMichael A, Conlon C, Wang X, Peng Y, Dong T.

Cancer Immunol Res. 2019 Aug;7(8):1293-1306. doi: 10.1158/2326-6066.CIR-18-0885. Epub 2019 Jun 18.

PMID:
31213473
4.

Artificial intelligence in digital pathology: a roadmap to routine use in clinical practice.

Colling R, Pitman H, Oien K, Rajpoot N, Macklin P; CM-Path AI in Histopathology Working Group, Snead D, Sackville T, Verrill C.

J Pathol. 2019 May 29. doi: 10.1002/path.5310. [Epub ahead of print]

PMID:
31144302
5.

Breast cancer outcome prediction with tumour tissue images and machine learning.

Turkki R, Byckhov D, Lundin M, Isola J, Nordling S, Kovanen PE, Verrill C, von Smitten K, Joensuu H, Lundin J, Linder N.

Breast Cancer Res Treat. 2019 Aug;177(1):41-52. doi: 10.1007/s10549-019-05281-1. Epub 2019 May 22.

6.

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.

Wu X, Scott H, Carlsson SV, Sjoberg DD, Cerundolo L, Lilja H, Prevo R, Rieunier G, Macaulay V, Higgins GS, Verrill CL, Lamb AD, Cunliffe VT, Bountra C, Hamdy FC, Bryant RJ.

Prostate. 2019 Jul;79(10):1079-1089. doi: 10.1002/pros.23817. Epub 2019 May 18.

7.

Reply to Maxine G. Tran, Ravi Barod, and Axel Bex's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.

Macklin PS, Sullivan ME, Tapping CR, Webster GM, Roberts ISD, Verrill CL, Browning L.

Eur Urol. 2019 Jun;75(6):e177-e178. doi: 10.1016/j.eururo.2019.02.029. Epub 2019 Mar 1. No abstract available.

PMID:
30827695
8.

The use of digital pathology and image analysis in clinical trials.

Pell R, Oien K, Robinson M, Pitman H, Rajpoot N, Rittscher J, Snead D, Verrill C; UK National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) quality assurance working group.

J Pathol Clin Res. 2019 Apr;5(2):81-90. doi: 10.1002/cjp2.127. Epub 2019 Mar 25.

9.

Training and accreditation standards for pathologists undertaking clinical trial work.

Rees G, Salto-Tellez M, Lee JL, Oien K, Verrill C, Freeman A, Mirabile I, West NP; National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) clinical trials working group.

J Pathol Clin Res. 2019 Apr;5(2):100-107. doi: 10.1002/cjp2.124. Epub 2019 Feb 27.

10.

Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre.

Macklin PS, Sullivan ME, Tapping CR, Cranston DW, Webster GM, Roberts ISD, Verrill CL, Browning L.

Eur Urol. 2019 May;75(5):861-867. doi: 10.1016/j.eururo.2018.12.011. Epub 2018 Dec 24.

PMID:
30591353
11.

Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours.

Linder N, Taylor JC, Colling R, Pell R, Alveyn E, Joseph J, Protheroe A, Lundin M, Lundin J, Verrill C.

J Clin Pathol. 2019 Feb;72(2):157-164. doi: 10.1136/jclinpath-2018-205328. Epub 2018 Dec 5.

PMID:
30518631
12.

An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells.

Freedman JD, Duffy MR, Lei-Rossmann J, Muntzer A, Scott EM, Hagel J, Campo L, Bryant RJ, Verrill C, Lambert A, Miller P, Champion BR, Seymour LW, Fisher KD.

Cancer Res. 2018 Dec 15;78(24):6852-6865. doi: 10.1158/0008-5472.CAN-18-1750. Epub 2018 Nov 18.

PMID:
30449733
13.

Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work.

Robinson M, James J, Thomas G, West N, Jones L, Lee J, Oien K, Freeman A, Craig C, Sloan P, Elliot P, Cheang M, Rodriguez-Justo M, Verrill C; UK National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) clinical trials working group.

J Pathol Clin Res. 2019 Apr;5(2):91-99. doi: 10.1002/cjp2.121. Epub 2018 Nov 29.

14.

Barriers to the release of human tissue for clinical trials research in the UK: a national survey of cellular pathology laboratories on behalf of the National Cancer Research Institute's Cellular Molecular Pathology (CM-Path) initiative.

Macklin PS, Hall A, Lee J, Hair J, Speirs V, Thomas GJ, Oien KA, Verrill C.

J Clin Pathol. 2019 Jan;72(1):52-57. doi: 10.1136/jclinpath-2018-205476. Epub 2018 Oct 1.

PMID:
30275096
15.

Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.

Bryant RJ, Hobbs CP, Eyre KS, Davies LC, Sullivan ME, Shields W, Sooriakumaran P, Verrill CL, Gleeson FV, MacPherson RE, Hamdy FC, Brewster SF.

J Urol. 2019 Mar;201(3):510-519. doi: 10.1016/j.juro.2018.09.049.

PMID:
30266332
16.

Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.

Hamdy FC, Elliott D, le Conte S, Davies LC, Burns RM, Thomson C, Gray R, Wolstenholme J, Donovan JL, Fitzpatrick R, Verrill C, Gleeson F, Singh S, Rosario D, Catto JW, Brewster S, Dudderidge T, Hindley R, Emara A, Sooriakumaran P, Ahmed HU, Leslie TA.

Health Technol Assess. 2018 Sep;22(52):1-96. doi: 10.3310/hta22520.

17.

Prostatic capsular incision during radical prostatectomy has important oncological implications: a systematic review and meta-analysis.

Philippou Y, Harriss E, Davies L, Jubber I, Leslie T, Bell RW, Bryant RJ, Hamdy FC, Verrill C, Lamb AD.

BJU Int. 2018 Aug 16. doi: 10.1111/bju.14522. [Epub ahead of print] Review.

18.

Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage.

Aleksic T, Gray N, Wu X, Rieunier G, Osher E, Mills J, Verrill C, Bryant RJ, Han C, Hutchinson K, Lambert AG, Kumar R, Hamdy FC, Weyer-Czernilofsky U, Sanderson MP, Bogenrieder T, Taylor S, Macaulay VM.

Cancer Res. 2018 Jul 1;78(13):3497-3509. doi: 10.1158/0008-5472.CAN-17-3498. Epub 2018 May 7.

19.

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.

Wedge DC, Gundem G, Mitchell T, Woodcock DJ, Martincorena I, Ghori M, Zamora J, Butler A, Whitaker H, Kote-Jarai Z, Alexandrov LB, Van Loo P, Massie CE, Dentro S, Warren AY, Verrill C, Berney DM, Dennis N, Merson S, Hawkins S, Howat W, Lu YJ, Lambert A, Kay J, Kremeyer B, Karaszi K, Luxton H, Camacho N, Marsden L, Edwards S, Matthews L, Bo V, Leongamornlert D, McLaren S, Ng A, Yu Y, Zhang H, Dadaev T, Thomas S, Easton DF, Ahmed M, Bancroft E, Fisher C, Livni N, Nicol D, Tavaré S, Gill P, Greenman C, Khoo V, Van As N, Kumar P, Ogden C, Cahill D, Thompson A, Mayer E, Rowe E, Dudderidge T, Gnanapragasam V, Shah NC, Raine K, Jones D, Menzies A, Stebbings L, Teague J, Hazell S, Corbishley C; CAMCAP Study Group, de Bono J, Attard G, Isaacs W, Visakorpi T, Fraser M, Boutros PC, Bristow RG, Workman P, Sander C; TCGA Consortium, Hamdy FC, Futreal A, McDermott U, Al-Lazikani B, Lynch AG, Bova GS, Foster CS, Brewer DS, Neal DE, Cooper CS, Eeles RA.

Nat Genet. 2018 May;50(5):682-692. doi: 10.1038/s41588-018-0086-z. Epub 2018 Apr 16.

20.

Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patient re-classification?

Bryant RJ, Yang B, Philippou Y, Lam K, Obiakor M, Ayers J, Chiocchia V, Gleeson F, MacPherson R, Verrill C, Sooriakumaran P, Hamdy FC, Brewster SF.

BJU Int. 2018 Nov;122(5):794-800. doi: 10.1111/bju.14248. Epub 2018 May 9.

PMID:
29645347
21.

Intraoperative Consultation and Macroscopic Handling: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations.

Verrill C, Perry-Keene J, Srigley JR, Zhou M, Humphrey PA, Lopez-Beltran A, Egevad L, Ulbright TM, Tickoo SK, Epstein JI, Compérat E, Berney DM; Members of the ISUP Testicular Tumor Panel.

Am J Surg Pathol. 2018 Jun;42(6):e33-e43. doi: 10.1097/PAS.0000000000001049.

PMID:
29579010
22.

Bilateral Testicular Germ Cell Tumors: A Case-Series From a UK-Based Tertiary Referral Center Over 19 Years.

Watson RA, Morgan RD, Joseph J, Sivakumar S, Verrill C, Tuthill M, Sullivan M, Protheroe AS.

Clin Genitourin Cancer. 2018 Jun;16(3):e513-e516. doi: 10.1016/j.clgc.2018.02.020. Epub 2018 Mar 2. No abstract available.

PMID:
29566999
23.

Deep learning based tissue analysis predicts outcome in colorectal cancer.

Bychkov D, Linder N, Turkki R, Nordling S, Kovanen PE, Verrill C, Walliander M, Lundin M, Haglund C, Lundin J.

Sci Rep. 2018 Feb 21;8(1):3395. doi: 10.1038/s41598-018-21758-3.

24.

Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.

Robbe P, Popitsch N, Knight SJL, Antoniou P, Becq J, He M, Kanapin A, Samsonova A, Vavoulis DV, Ross MT, Kingsbury Z, Cabes M, Ramos SDC, Page S, Dreau H, Ridout K, Jones LJ, Tuff-Lacey A, Henderson S, Mason J, Buffa FM, Verrill C, Maldonado-Perez D, Roxanis I, Collantes E, Browning L, Dhar S, Damato S, Davies S, Caulfield M, Bentley DR, Taylor JC, Turnbull C, Schuh A; 100,000 Genomes Project.

Genet Med. 2018 Oct;20(10):1196-1205. doi: 10.1038/gim.2017.241. Epub 2018 Feb 1.

25.

Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.

Gonnissen A, Isebaert S, Perneel C, McKee CM, Van Utterbeeck F, Lerut E, Verrill C, Bryant RJ, Joniau S, Muschel RJ, Haustermans K.

Am J Pathol. 2018 Mar;188(3):795-804. doi: 10.1016/j.ajpath.2017.11.019. Epub 2018 Jan 12.

26.

Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional Center.

Tyrrell HEJ, Church DN, Joseph J, Traill ZC, Sullivan ME, Tuthill MH, Verrill CL, Pintus EP, Dallas NL, Rogers PB, Redgwell J, Protheroe AS.

Clin Genitourin Cancer. 2018 Jun;16(3):240-244. doi: 10.1016/j.clgc.2017.12.001. Epub 2017 Dec 11.

PMID:
29336917
27.

Systematic Review of Studies Reporting Positive Surgical Margins After Bladder Neck Sparing Radical Prostatectomy.

Bellangino M, Verrill C, Leslie T, Bell RW, Hamdy FC, Lamb AD.

Curr Urol Rep. 2017 Nov 7;18(12):99. doi: 10.1007/s11934-017-0745-0. Review.

28.

Incidentally detected testicular lesions <10 mm in diameter: can orchidectomy be avoided?

Scandura G, Verrill C, Protheroe A, Joseph J, Ansell W, Sahdev A, Shamash J, Berney DM.

BJU Int. 2018 Apr;121(4):575-582. doi: 10.1111/bju.14056. Epub 2017 Nov 12.

29.

IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer.

Aleksic T, Verrill C, Bryant RJ, Han C, Worrall AR, Brureau L, Larré S, Higgins GS, Fazal F, Sabbagh A, Haider S, Buffa FM, Cole D, Macaulay VM.

Br J Cancer. 2017 Nov 21;117(11):1600-1606. doi: 10.1038/bjc.2017.337. Epub 2017 Oct 3.

30.

Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.

Camacho N, Van Loo P, Edwards S, Kay JD, Matthews L, Haase K, Clark J, Dennis N, Thomas S, Kremeyer B, Zamora J, Butler AP, Gundem G, Merson S, Luxton H, Hawkins S, Ghori M, Marsden L, Lambert A, Karaszi K, Pelvender G, Massie CE, Kote-Jarai Z, Raine K, Jones D, Howat WJ, Hazell S, Livni N, Fisher C, Ogden C, Kumar P, Thompson A, Nicol D, Mayer E, Dudderidge T, Yu Y, Zhang H, Shah NC, Gnanapragasam VJ; CRUK-ICGC Prostate Group, Isaacs W, Visakorpi T, Hamdy F, Berney D, Verrill C, Warren AY, Wedge DC, Lynch AG, Foster CS, Lu YJ, Bova GS, Whitaker HC, McDermott U, Neal DE, Eeles R, Cooper CS, Brewer DS.

PLoS Genet. 2017 Sep 25;13(9):e1007001. doi: 10.1371/journal.pgen.1007001. eCollection 2017 Sep.

31.

Tissue microarray analysis indicates hedgehog signaling as a potential prognostic factor in intermediate-risk prostate cancer.

Gonnissen A, Isebaert S, Perneel C, McKee CM, Verrill C, Bryant RJ, Van Utterbeeck F, Lerut E, Haustermans K, Muschel RJ.

BMC Cancer. 2017 Sep 6;17(1):634. doi: 10.1186/s12885-017-3619-4.

32.

No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer.

De La Pena H, Sharma A, Glicksman C, Joseph J, Subesinghe M, Traill Z, Verrill C, Sullivan M, Redgwell J, Bataillard E, Pintus E, Dallas N, Gogbashian A, Tuthill M, Protheroe A, Hall M.

Eur J Cancer. 2017 Oct;84:354-359. doi: 10.1016/j.ejca.2017.07.005. Epub 2017 Sep 1.

PMID:
28866371
33.

TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy.

Pirovano G, Ashton TM, Herbert KJ, Bryant RJ, Verrill CL, Cerundolo L, Buffa FM, Prevo R, Harrap I, Ryan AJ, Macaulay V, McKenna WG, Higgins GS.

Br J Cancer. 2017 Aug 8;117(4):503-512. doi: 10.1038/bjc.2017.197. Epub 2017 Jul 4.

34.

Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer.

Purshouse K, Schuh A, Fairfax BP, Knight S, Antoniou P, Dreau H, Popitsch N, Gatter K, Roberts I, Browning L, Traill Z, Kerr D, Verrill C, Tuthill M, Taylor JC, Protheroe A.

Cold Spring Harb Mol Case Stud. 2017 May;3(3):a001362. doi: 10.1101/mcs.a001362.

35.

Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations.

Verrill C, Yilmaz A, Srigley JR, Amin MB, Compérat E, Egevad L, Ulbright TM, Tickoo SK, Berney DM, Epstein JI; Members of the International Society of Urological Pathology Testicular Tumor Panel.

Am J Surg Pathol. 2017 Jun;41(6):e22-e32. doi: 10.1097/PAS.0000000000000844.

PMID:
28368923
36.

The drebrin/EB3 pathway drives invasive activity in prostate cancer.

Dart AE, Worth DC, Muir G, Chandra A, Morris JD, McKee C, Verrill C, Bryant RJ, Gordon-Weeks PR.

Oncogene. 2017 Jul 20;36(29):4111-4123. doi: 10.1038/onc.2017.45. Epub 2017 Mar 20.

37.

UICC drops the ball in the 8th edition TNM staging of urological cancers.

Delahunt B, Egevad L, Samaratunga H, Varma M, Verrill C, Cheville J, Kristiansen G, Corbishley C, Berney DM.

Histopathology. 2017 Jul;71(1):5-11. doi: 10.1111/his.13200. No abstract available.

PMID:
28239904
38.

Value of Supraregional Multidisciplinary Review for the Contemporary Management of Testicular Tumors.

Purshouse K, Watson RA, Church DN, Richardson C, Crane G, Traill Z, Sullivan M, Roberts I, Browning L, Turner G, Parameshwaran V, Johnson J, Chitnis M, Protheroe A, Verrill C.

Clin Genitourin Cancer. 2017 Feb;15(1):152-156. doi: 10.1016/j.clgc.2016.05.005. Epub 2016 May 27.

PMID:
27324054
39.

Visualizing the origins of selfish de novo mutations in individual seminiferous tubules of human testes.

Maher GJ, McGowan SJ, Giannoulatou E, Verrill C, Goriely A, Wilkie AO.

Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):2454-9. doi: 10.1073/pnas.1521325113. Epub 2016 Feb 8.

40.

Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.

Verrill C, Cerundolo L, Mckee C, White M, Kartsonaki C, Fryer E, Morris E, Brewster S, Ratnayaka I, Marsden L, Lilja H, Muschel R, Lu X, Hamdy F, Bryant RJ.

Oncotarget. 2016 Jan 12;7(2):1107-19. doi: 10.18632/oncotarget.6689.

41.

Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.

Pfister SX, Markkanen E, Jiang Y, Sarkar S, Woodcock M, Orlando G, Mavrommati I, Pai CC, Zalmas LP, Drobnitzky N, Dianov GL, Verrill C, Macaulay VM, Ying S, La Thangue NB, D'Angiolella V, Ryan AJ, Humphrey TC.

Cancer Cell. 2015 Nov 9;28(5):557-568. doi: 10.1016/j.ccell.2015.09.015.

42.

Bile duct basement membrane thickening in primary sclerosing cholangitis.

Colling R, Verrill C, Fryer E, Kartsonaki C, Wang LM, Chapman R, Rajabally N, Fleming K.

Histopathology. 2016 May;68(6):819-24. doi: 10.1111/his.12857. Epub 2015 Oct 23.

PMID:
26333410
43.

Variation between specialist uropatholgists in reporting extraprostatic extension after radical prostatectomy.

Bryant RJ, Schmitt AJ, Roberts IS, Gill PS, Browning L, Brewster SF, Hamdy FC, Verrill C.

J Clin Pathol. 2015 Jun;68(6):465-72. doi: 10.1136/jclinpath-2014-202661. Epub 2015 Mar 19. Erratum in: J Clin Pathol. 2015 Jul;68(7):e2.

PMID:
25792751
44.

Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists.

Berney DM, Algaba F, Amin M, Delahunt B, Compérat E, Epstein JI, Humphrey P, Idrees M, Lopez-Beltran A, Magi-Galluzzi C, Mikuz G, Montironi R, Oliva E, Srigley J, Reuter VE, Trpkov K, Ulbright TM, Varma M, Verrill C, Young RH, Zhou M, Egevad L.

Histopathology. 2015 Sep;67(3):313-24. doi: 10.1111/his.12657. Epub 2015 Mar 17.

45.

The genomic diversity of prostate cancer: our Achilles heel explored.

Bryant RJ, Verrill C, Hamdy FC.

Eur Urol. 2015 May;67(5):823-4. doi: 10.1016/j.eururo.2014.11.026. Epub 2014 Nov 26. No abstract available.

PMID:
25433913
46.

Nuclear iASPP may facilitate prostate cancer progression.

Morris EV, Cerundolo L, Lu M, Verrill C, Fritzsche F, White MJ, Thalmann GN, ten Donkelaar CS, Ratnayaka I, Salter V, Hamdy FC, Lu X, Bryant RJ.

Cell Death Dis. 2014 Oct 23;5:e1492. doi: 10.1038/cddis.2014.442.

47.

A case-control study of occupational exposure to metalworking fluids and bladder cancer risk among men.

Colt JS, Friesen MC, Stewart PA, Donguk P, Johnson A, Schwenn M, Karagas MR, Armenti K, Waddell R, Verrill C, Ward MH, Freeman LE, Moore LE, Koutros S, Baris D, Silverman DT.

Occup Environ Med. 2014 Oct;71(10):667-74. doi: 10.1136/oemed-2013-102056. Epub 2014 Jun 20.

48.

Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling.

Gao S, Bajrami I, Verrill C, Kigozi A, Ouaret D, Aleksic T, Asher R, Han C, Allen P, Bailey D, Feller S, Kashima T, Athanasou N, Blay JY, Schmitz S, Machiels JP, Upile N, Jones TM, Thalmann G, Ashraf SQ, Wilding JL, Bodmer WF, Middleton MR, Ashworth A, Lord CJ, Macaulay VM.

Cancer Res. 2014 Oct 15;74(20):5866-77. doi: 10.1158/0008-5472.CAN-14-0806. Epub 2014 Aug 28.

49.

0084 A Case-Control Study of Occupational Exposure to Metalworking Fluids and Bladder Cancer Risk among Men.

Colt J, Friesen M, Stewart P, Donguk P, Johnson A, Schwenn M, Karagas M, Armenti K, Waddell R, Verrill C, Ward M, Beane Freeman L, Moore L, Baris D, Silverman D.

Occup Environ Med. 2014 Jun;71 Suppl 1:A71. doi: 10.1136/oemed-2014-102362.221.

50.

Discrepancy rates in liver biopsy reporting.

Colling R, Verrill C, Fryer E, Wang LM, Fleming K.

J Clin Pathol. 2014 Sep;67(9):825-7.

PMID:
24970902

Supplemental Content

Loading ...
Support Center